Cambium Bio LtdASX: CMB

Notification regarding unquoted securities - CMB

Sep 22, 2026 at 8:10 PM EDT · Issued by Cambium Bio Ltd via ASX

Filed with ASX · Sep 22, 2026 at 8:10 PM EDT · 6 pages · English

On 6ix: 6ix.com/news/notification-regarding-unquoted-securities-cmb

Release

Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securitiesAppendix 3G - Notification of issue, conversion or payment up of unquoted equity securities1 / 6Announcement SummaryEntity nameCAMBIUM BIO LIMITEDDate of this announcementWednesday September 23, 2026The...

Cambium Bio Ltd on 6ix

Earlier from Cambium Bio

Cambium Bio Secures A$10.85 Million to Initiate Pivotal Phase 3 Trial of Elate Ocular®, a Potential First-in-Class Biologic for Dry Eye DiseaseSep 16
Cambium Bio Secures A$10.85 Million Funding PackageSep 15
Proposed issue of securities - CMBSep 15
Notice of ceasing to be a substantial holderSep 15
Change in Substantial HoldingSep 15

Later from Cambium Bio

Notification of cessation of securities - CMBSep 23
Date of AGM and Closing Date for Director NominationsSep 27
Corporate Presentation - September 2026Sep 29
Notice of Annual General Meeting and Proxy formOct 7
Access Letter and Online Meeting GuideOct 7

All Cambium Bio news releases

Follow Cambium Bio into a list and get an email when it puts out news.

Follow Cambium Bio